ECL1i (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P11553A-5MG | 5 mg | 149,00 | Add | |
| HY-P11553A-10MG | 10 mg | 233,00 | Add | |
| HY-P11553A-25MG | 25 mg | 447,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
ECL1i TFA is an allosteric, selective CCR2 inhibitor. ECL1i TFA specifically inhibits CCL2-/CCR2-mediated chemotaxis. ECL1i TFA interferes with CCR2-positive cell recruitment and attenuates disease progression in experimental autoimmune encephalomyelitis[1].
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Infection;Inflammation/Immunology |
| Grade | Clinical information: No Development Reported |
| Purity | 97.36% |
| Molecular Formula | C38H61F3N8O11S |
| Molecular Weight | 895 |
| Storage Conditions | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture) |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
